This document is page 37 of a Cowen Collaborative Insights market research report dated February 25, 2019. It visually compares four CBD topical products from companies Mary's Medicinals, Curaleaf, Highline, and Reliva, noting packaging and pricing strategies. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a Congressional investigation.
| Name | Role | Context |
|---|---|---|
| Michael Cella | Recipient/Employee |
Email address listed in the sidebar watermark indicating the report is intended for him.
|
| Name | Type | Context |
|---|---|---|
| Cowen |
Financial services firm that produced the report (Cowen Collaborative Insights).
|
|
| Mary's Medicinals |
Company whose product (Muscle Freeze) is analyzed in Figure 53.
|
|
| Curaleaf |
Company whose product (Hemp Lotion) is analyzed in Figure 54.
|
|
| Highline |
Company whose product (Premium CBD Cream) is analyzed in Figure 55.
|
|
| Reliva |
Company whose product (CBD Pain Cream) is analyzed in Figure 56.
|
|
| House Oversight Committee |
Implied by the Bates stamp 'HOUSE_OVERSIGHT_024853'.
|
"Mary's Provides A Range Of Topicals, Including Muscle Freeze"Source
"Curaleaf Hemp Lotion Priced On The Premium Side"Source
"Highline Positioned Within Mainstream"Source
"Reliva's Pain Cream Retails For $19.99"Source
Complete text extracted from the document (1,050 characters)
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document